The diagnostic value of ML integrated with laboratory signatures that (luteinizing hormone (LH)/follicle-stimulating hormone (FSH), progesterone, anti-Müllerian hormone (AMH), total cholesterol, triglyceride, and high-density lipoprotein cholesterol) or three clinical indicators (LH, LH/FSH, and AMH) has the potential to significantly improve the Acc of diagnosing PCOS patients [98–100]. The gene discussed is BRD2; the disease is polycystic ovary syndrome.